|
Pregene and Dr. Reddy’s Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
|
Shenzhen Pregene Biopharma and Dr. Reddy's Laboratories announce a license agreement whereby Dr Reddy's will acquire the exclusive rights in the Republic of India for PRG1801, an anti-BCMA CAR-T cell therapy injection based on single...
Full "IntellAsia: Resources" article
|
|